When was keytruda's initial fda approval?

When did FDA first approve Keytruda (pembrolizumab)?

Keytruda (pembrolizumab) received its initial FDA approval on September 4, 2014. [1]

What was Keytruda’s first FDA approval for?

FDA first approved Keytruda for the treatment of unresectable or metastatic melanoma in patients with progression on or after other therapies, or for whom no satisfactory alternative treatment options existed. [1]

Does the approval date differ by cancer type or label expansion?

The FDA’s initial approval date stays the same, but Keytruda’s label has expanded over time to include additional cancers and treatment settings after 2014. [1]

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514